Skip to content

Clinical trials

Completed Carcinoma, Non-Small-Cell Lung trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Not applicable Status: Completed Clear all

221 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20023
20034
20047
20058
200612
20075
20089
200913
20109
20119
201213
20138
20149
20159
201615
201712
201816
20198
20207
20219
202211
20232
20246
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed221

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital7
City of Hope Medical Center6
M.D. Anderson Cancer Center6
National Cancer Institute (NCI)5
Alliance for Clinical Trials in Oncology4
Fox Chase Cancer Center4
Stanford University4
University Health Network, Toronto4
Centre Henri Becquerel3
Instituto Nacional de Cancerologia de Mexico3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung221
Lung Neoplasms88
Small Cell Lung Carcinoma25
Breast Neoplasms16
Colonic Neoplasms12
Colorectal Neoplasms11
Esophageal Neoplasms11
Prostatic Neoplasms11
Carcinoma, Renal Cell10
Urinary Bladder Neoplasms10

Trials

Showing 1 to 25 of 221. Each trial links to its page on Pharma Observatory.

121 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.